Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Japan Tobacco Inc and Torii Pharmaceutical Co Ltd receive approval for hyperphosphatemia tablet Riona


Friday, 17 Jan 2014 02:00am EST 

Japan Tobacco Inc and Torii Pharmaceutical Co Ltd:Says received manufacturing and marketing approval of Riona Tablets 250mg, which is jointly developed by the two companies, from the Japanese Ministry of Health, Labour and Welfare.Says the drug is indicated as an oral treatment for the improvement of hyperphosphatemia in patients1 with chronic kidney disease (CKD).Says Riona Tablets is a novel phosphate binder containing ferric citrate hydrate as the active pharmaceutical ingredient. 

Company Quote

3433.5
33.5 +0.99%
25 Dec 2014